Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More

October 25, 2024
Alex Biese
Alex Biese

A nationally-published, award-winning journalist, Alex Biese joined the CURE team as an assistant managing editor in April 2023. Prior to that, Alex's work was published in outlets including the Chicago Sun-Times, MTV.com, USA TODAY and the Press of Atlantic City. Alex is a member of NLGJA: The Association of LGBTQ+ Journalists, and also performs at the Jersey Shore with the acoustic jam band Somewhat Relative.

,
Ashley Chan

Ashley Chan, assistant editor for CURE®, has been with MJH Life Sciences since June 2023. She graduated with a B.A. in Communication Studies from Rowan University. Outside of work, Ashley enjoys spending time with family and friends, reading new novels by Asian American authors, and working on the manuscript of her New Adult novel.

From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.

“The Office” star Jenna Fischer shared breast cancer details in a new interview.

Actress Jenna Fischer, known for her time as Pam on the hit sitcom “The Office,” shared details of her recent breast cancer journey in an interview with Hoda Kotb on the Oct. 21 episode of “TODAY.”

Fischer received a diagnosis of stage 1 triple-positive breast cancer in December 2023, and in an Oct. 8 Instagram post, she announced that following surgery, chemotherapy and radiation, she is cancer-free. However, Fischer told “TODAY” she will continue to take tamoxifen and Herceptin (trastuzumab) for the next year.

Fischer advised viewers not to skip mammogram appointments and to “get all the extra screenings that the doctor wants you to get.”

“If I had waited six more months, it could have been much worse. It could have spread. It was a very aggressive form of cancer,” she said. “I’m really lucky that my cancer had not spread into my lymph nodes. It hadn’t spread anywhere else in my body.”

Los Angeles Dodgers broadcaster Charley Steiner’s multiple myeloma is in remission.

Charley Steiner, a broadcaster for the Los Angeles Dodgers baseball team, learned on Oct. 21 that his multiple myeloma, a type of blood cancer, is in remission, according to the Los Angeles Times.

“Remission is a beautiful word,” Steiner said, according to the Times. “Monday was one of those days where it’s like, OK, we’re good.”

Steiner, 75, received his diagnosis nearly a year ago but had kept his cancer journey private until this week, according to the report. Steiner, whose symptoms began with back pain in November 2023, was treated at City of Hope.

Due to his illness, he was forced to miss the Dodgers’ season, which will see the team face the New York Yankees in the World Series.

Jack Jones, “Love Boat” theme singer, died of cancer.

Grammy-winning singer Jack Jones died Oct. 23 of leukemia at 86 years old.

Jones’ wife, Elenora, announced that his cause of death was because of complications from leukemia and died in the hospital.

Jones was well-known for hits, including “Lollipops and Roses,” “Wives and Lovers,” “The Impossible Dream” and the theme song for ABC’s “The Love Boat.”

Olympic cyclist announced metastatic prostate cancer diagnosis.

Chris Hoy, 48, a six-time Olympic champion from Great Britain, recently shared that he has metastatic prostate cancer that spread to his bones.

He explained to The Sunday Times that he had visited the hospital in September 2023 after experiencing shoulder pain. Hoy then underwent scans, which revealed that he had an existing tumor in his shoulder, primary cancer in his prostate, and metastases in his pelvis, hip, spine and rib.

“As unnatural as it feels, this is nature. You know, we were all born and we all die, and this is just part of the process,” he told the news outlet. “Hand on heart, I’m pretty positive most of the time and I have genuine happiness. This is bigger than the Olympics. It’s bigger than anything. This is about appreciating life and finding joy.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.